Hepatica is a clinical and surgical decision support tool designed to improve the accuracy of liver health and volume assessment. It uses artificial intelligence to delineate liver volume and individual Couinaud segments from MRI scans, providing clinicians with robust, quantifiable metrics in a single comprehensive report. Hepatica supports pre-surgical decision-making for patients with liver cancer, helping identify those at risk of poor post-operative outcomes and enabling safer surgical planning. The software is delivered via a PACS-integrated cloud-based service, ensuring seamless integration into clinical workflows. Built on LiverMultiScan technology, Hepatica provides validated biomarkers of liver health (cT1 and PDFF) and 3D visualization of liver volume.

Features

• AI-driven delineation of liver volume and Couinaud segments.
• Quantitative assessment of liver fibro-inflammation (cT1), fat (PDFF), and volume.
• Whole liver and segmental analysis using multiparametric MRI.
• PACS-integrated cloud-based delivery for seamless workflow integration.
• No radiation risk due to MRI-based imaging.
• Clinically validated metrics for pre-operative liver health assessment.
• Supports stratification of surgical risk and estimation of future liver remnant (FLR).

Benefits

• Improves surgical planning and reduces post-operative complications.
• Enables identification of patients at risk of poor outcomes and longer hospital stays.
• Provides accurate and reproducible liver health metrics.
• Enhances clinical decision-making with comprehensive, patient-friendly reports.
• Potential cost savings through reduced complication rates and shorter hospital stays.
• Safe and non-invasive imaging method with no need for contrast agents.